Literature DB >> 23996721

Fabry disease: a rare cause of neuropathic pain.

Marieke Biegstraaten1, Gabor E Linthorst, Ivo N van Schaik, Carla E M Hollak.   

Abstract

Fabry disease is characterized by burning or shooting pains in hands and feet, which have a severe impact on the quality of life of patients. It is therefore of importance that Fabry patients receive adequate diagnosis, counseling, treatment and follow up. This review describes neuropathic pain in classical Fabry disease with the aim to help clinicians to recognize Fabry patients among patients presenting with chronic extremity pain. The diagnostic dilemmas in patients with neuropathic pain and a non-classical disease course are discussed, together with the available diagnostic modalities, pain medication options and the effect of enzyme replacement therapy on small fiber neuropathy.

Entities:  

Mesh：

Year:  2013        PMID： 23996721     DOI： 10.1007/s11916-013-0365-4

Source DB:  PubMed          Journal:  Curr Pain Headache Rep        ISSN： 1534-3081


  54 in total

1.  Disease manifestations and X inactivation in heterozygous females with Fabry disease.

Authors:  Esther M Maier; Stephanie Osterrieder; Catharina Whybra; Markus Ries; Andreas Gal; Michael Beck; Adelbert A Roscher; Ania C Muntau
Journal:  Acta Paediatr Suppl       Date:  2006-04

2.  The relation between small nerve fibre function, age, disease severity and pain in Fabry disease.

Authors:  Marieke Biegstraaten; Andreas Binder; Rainer Maag; Carla E M Hollak; Ralf Baron; Ivo N van Schaik
Journal:  Eur J Pain       Date:  2011-02-22       Impact factor: 3.931

3.  Misdiagnosis in Fabry disease.

Authors:  Cintia L Marchesoni; Norma Roa; Ana María Pardal; Pablo Neumann; Guillermo Cáceres; Pablo Martínez; Isaac Kisinovsky; Silvia Bianchi; Ana Lía Tarabuso; Ricardo C Reisin
Journal:  J Pediatr       Date:  2010-05       Impact factor: 4.406

4.  Loss of small peripheral sensory neurons in Fabry disease. Histologic and morphometric evaluation of cutaneous nerves, spinal ganglia, and posterior columns.

Authors:  A Onishi; P J Dyck
Journal:  Arch Neurol       Date:  1974-08

5.  Functional and structural nerve fiber findings in heterozygote patients with Fabry disease.

Authors:  Anette Torvin Møller; Flemming Winther Bach; Ulla Feldt-Rasmussen; Ase Rasmussen; Lis Hasholt; He Lan; Claudia Sommer; Steen Kølvraa; Martin Ballegaard; Troels Staehelin Jensen
Journal:  Pain       Date:  2009-08-07       Impact factor: 6.961

6.  An atypical variant of Fabry's disease in men with left ventricular hypertrophy.

Authors:  S Nakao; T Takenaka; M Maeda; C Kodama; A Tanaka; M Tahara; A Yoshida; M Kuriyama; H Hayashibe; H Sakuraba
Journal:  N Engl J Med       Date:  1995-08-03       Impact factor: 91.245

7.  Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey.

Authors:  A Mehta; R Ricci; U Widmer; F Dehout; A Garcia de Lorenzo; C Kampmann; A Linhart; G Sunder-Plassmann; M Ries; M Beck
Journal:  Eur J Clin Invest       Date:  2004-03       Impact factor: 4.686

8.  Neurology of Fabry disease.

Authors:  M Low; K Nicholls; N Tubridy; P Hand; D Velakoulis; L Kiers; P Mitchell; G Becker
Journal:  Intern Med J       Date:  2007-07       Impact factor: 2.048

9.  Impaired small fiber conduction in patients with Fabry disease: a neurophysiological case-control study.

Authors:  Nurcan Üçeyler; Ann-Kathrin Kahn; Daniela Kramer; Daniel Zeller; Jordi Casanova-Molla; Christoph Wanner; Frank Weidemann; Zaza Katsarava; Claudia Sommer
Journal:  BMC Neurol       Date:  2013-05-24       Impact factor: 2.474

10.  Long-term outcome of enzyme-replacement therapy in advanced Fabry disease: evidence for disease progression towards serious complications.

Authors:  F Weidemann; M Niemann; S Störk; F Breunig; M Beer; C Sommer; S Herrmann; G Ertl; C Wanner
Journal:  J Intern Med       Date:  2013-05-06       Impact factor: 8.989
View more
  6 in total

1.  Detecting ordered small molecule drug aggregates in live macrophages: a multi-parameter microscope image data acquisition and analysis strategy.

Authors:  Phillip Rzeczycki; Gi Sang Yoon; Rahul K Keswani; Sudha Sud; Kathleen A Stringer; Gus R Rosania
Journal:  Biomed Opt Express       Date:  2017-01-13       Impact factor: 3.732

2.  Recommendations for the inclusion of Fabry disease as a rare febrile condition in existing algorithms for fever of unknown origin.

Authors:  Raffaele Manna; Roberto Cauda; Sandro Feriozzi; Giovanni Gambaro; Antonio Gasbarrini; Didier Lacombe; Avi Livneh; Alberto Martini; Huri Ozdogan; Antonio Pisani; Eleonora Riccio; Elena Verrecchia; Lorenzo Dagna
Journal:  Intern Emerg Med       Date:  2017-07-19       Impact factor: 3.397

Review 3.  Ion channels and pain in Fabry disease.

Authors:  Carina Weissmann; Adriana A Albanese; Natalia E Contreras; María N Gobetto; Libia C Salinas Castellanos; Osvaldo D Uchitel
Journal:  Mol Pain       Date:  2021 Jan-Dec       Impact factor: 3.395

4.  Prevalence of Raynaud phenomenon and nailfold capillaroscopic abnormalities in Fabry disease: a cross-sectional study.

Authors:  Samuel Deshayes; Laurent Auboire; Roland Jaussaud; Olivier Lidove; Jean-Jacques Parienti; Nathalie Triclin; Bernard Imbert; Boris Bienvenu; Achille Aouba
Journal:  Medicine (Baltimore)       Date:  2015-05       Impact factor: 1.889

Review 5.  Pain management strategies for neuropathic pain in Fabry disease--a systematic review.

Authors:  Y Schuller; G E Linthorst; C E M Hollak; I N Van Schaik; M Biegstraaten
Journal:  BMC Neurol       Date:  2016-02-24       Impact factor: 2.474

6.  No Fabry Disease in Patients Presenting with Isolated Small Fiber Neuropathy.

Authors:  Bianca T A de Greef; Janneke G J Hoeijmakers; Emma E Wolters; Hubertus J M Smeets; Arthur van den Wijngaard; Ingemar S J Merkies; Catharina G Faber; Monique M Gerrits
Journal:  PLoS One       Date:  2016-02-11       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.